<< Read Full Article
<< Read Full Article
GlaxoSmithKline, Pfizer Shine
- Loading Comments...
Big pharmaceutical companies were in the spotlight Saturday at the American Society of Clinical Oncology meeting in Atlanta.
Pfizer(PFE Quote) presented positive results for its experimental lung cancer drug Sutent.
The phase II safety and efficacy trial involved 63 patients who had received between one and four prior treatments for non-small cell lung cancer and were still getting worse. The patients underwent six-week cycles in which they received 50 milligrams of the drug per day for four weeks followed by a two-week break. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |


Connect with TheStreet